PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

2b or NOT to be, page-45

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    The Inflation Reduction Act is also not aimed at newly approved treatments. A company can simply bypass this act by not being offered under Medicare.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.